JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 7 November 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.01816-07v1
82/2/859    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giraldo-Vela, J. P.
Right arrow Articles by Watkins, D. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giraldo-Vela, J. P.
Right arrow Articles by Watkins, D. I.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.01816-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

The Major Histocompatibility Complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of SIV-infected rhesus macaque elite controllers

Juan P. Giraldo-Vela, Richard Rudersdorf, Chungwon Chung, Ying Qi, Lyle T. Wallace, Benjamin Bimber, Gretta J. Borchardt, Debra L. Fisk, Chrystal E. Glidden, John T. Loffredo, Shari M. Piaskowski, Jessica R. Furlott, Juan P. Morales-Martinez, Nancy A. Wilson, William M. Rehrauer, Jeffrey D. Lifson, Mary Carrington, and David I. Watkins*

Department of Pathology and Laboratory Medicine and Wisconsin National Primate Research Center (WNPRC), University of Wisconsin-Madison, Madison, WI 53715; Laboratory of Genomic Diversity, SAIC-Frederick, Inc., National Cancer Institute, Frederick, MD 21702; AIDS Vaccine Program/Basic Research Program, SAIC-Frederick, Inc., National Cancer Institute, Frederick, MD 21702

* To whom correspondence should be addressed. Email: watkins{at}primate.wisc.edu.


   Abstract

The role of CD4+ T cells in the control of human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) replication is not well understood. Even though strong HIV- and SIV-specific CD4+ T cell responses have been detected in individuals that control viral replication, MHC class II molecules have not been definitively linked with slow disease progression. In a cohort of 196 SIVmac239-infected Indian rhesus macaques, a group of macaques controlled viral replication to less than 1,000 viral RNA (vRNA) copies/ml. These elite controllers (ECs) mounted a broad SIV-specific CD4+ T cell response. Here we describe five macaque MHC class II alleles (Mamu-DRB*w606, -DRB*w2104, -DRB1*0306, -DRB1*1003 and -DPB1*06) that restricted six SIV-specific CD4+ T cell epitopes in ECs and report the first association between specific MHC class II alleles and elite control. Interestingly, the macaque MHC class II alleles, -DRB1*1003 and -DRB1*0306, were enriched in this EC group (p= 0.02 and p= 0.05, respectively). Additionally, Mamu-B*17-positive SIV-infected rhesus macaques that also expressed these two MHC class II alleles had significantly lower viral loads than Mamu-B*17-positive animals that did not express Mamu-DRB1*1003 and -DRB1*0306 (p=<0.0001). The study of MHC class II alleles in macaques that control viral replication could improve our understanding of the role of CD4+ T cells in suppressing HIV/SIV replication and further our understanding of HIV vaccine design.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.